Related Experiment Video
Updated: Jun 22, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
[Clinical presentation of renal cell carcinoma in renal transplant]
Raquel González-López1, Gonzalo Bueno-Serrano, Javier Mayor-De Castro
1Servicio de Urología, Universidad de Alcalá de Henares, Hospital Ramón y Cajal, Madrid, España. rakelgon@hotmail.com
Objectives:
To analyze the clinical presentation and therapeutic response of renal cell carcinoma (RCC) of the renal graft.
Methods:
Analysis of the cases described in our centre and review of current literature.
Results:
RCC has a higher incidence in transplant patients, affecting the graft in less than 10% of the cases. Detection is usually a casual event during follow-up due to the absence of innervation, although its presentation may be as an acute abdomen in case of breakage of the graft. Conventional treatment consists of transplant nephrectomy, but partial nephrectomy has been performed in recent years with good results. The modification of immunosuppression is a routine measure after treatment.
Conclusions:
The incidence of RCC after renal transplants in our series is 0.7%, of which 22% are originated in the graft. The clinical presentation of the primitive RCC of the graft is variable. Partial nephrectomy is technically feasible and oncologically safe in the treatment of RCC of the renal graft.
More Related Videos
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury III: Clinical Manifestations

